John Oates's Colleagues at Recombination Therapeutics
John Oates's Contact Details
HQ
Location
Philadelphia,Pennsylvania,United States
Philadelphia,Pennsylvania,United States
Company
Recombination Therapeutics
Recombination Therapeutics
John Oates's Company Details
Recombination Therapeutics is a discovery stage DNA Damage Response (DDR) biotechnology company focused on developing best-in-class personalized cancer therapeutics. Recombination Therapeutics was established in 2018 with the goal of developing next-generation precision medicines for cancers with genetic defects in the DNA repair pathway called homologous recombination. Recombination's lead program is targeting DNA polymerase Theta (Polq) which is essential for the proliferation of recombination deficient cancer cells, but is dispensable for normal cells.
Frequently Asked Questions about John Oates
John Oates currently works for Recombination Therapeutics.
John Oates's role at Recombination Therapeutics is Co-founder and CEO.
John Oates's email address is ***@recombinationtx.com. To view John Oates's full email address, please signup to ConnectPlex.
John Oates works in the Biotechnology industry.
John Oates's colleagues at Recombination Therapeutics are Richard Pomerantz and others.
John Oates's phone number is